Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37129853.
- Also identified by DOI 10.1021/acsnano.3c00920 and PMC identifier 10718652.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The RAS-transformed cells utilize macropinocytosis to acquire amino acids to support their uncontrolled growth. However, targeting RAS to inhibit macropinocytosis remains a challenge. Here, we report that gold nanoparticles (GNP) inhibit macropinocytosis by decreasing KRAS activation. Using surface-modified and unmodified GNP, we showed that unmodified GNP specifically sequestered both wild-type and mutant KRAS and inhibited its activation, irrespective of growth factor stimulation, while surface-passivated GNP had no effect. Alteration of KRAS activation is reflected on downstream signaling cascades, macropinocytosis and tumor cell growth <i>in vitro</i>, and two independent preclinical human xenograft models of pancreatic cancer <i>in vivo</i>. The current study demonstrates NP-mediated inhibition of macropinocytosis and KRAS activation and provides translational opportunities to inhibit tumor growth in a number of cancers where activation of KRAS plays a major role.
Medical subject headings
- Metal Nanoparticles
- Pancreatic Neoplasms